Jeffrey S. Farrow's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 27,881 Restricted Stock Units done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 27,881 | 27,882 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 27,881 | 71,197 | - | - | Common Stock | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 60.95 per share. | 15 Jun 2026 | 14,396 | 56,801 | - | 60.9 | 877,436 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 67.00 per share. | 17 Mar 2026 | 2,186 | 43,316 | - | 67 | 146,462 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 68.71 per share. | 17 Mar 2026 | 2,133 | 45,502 | - | 68.7 | 146,558 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 69.42 per share. | 17 Mar 2026 | 2,111 | 47,635 | - | 69.4 | 146,546 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 13,042 | 49,746 | - | - | Common Stock | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 8,020 | 16,040 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 5,022 | 15,067 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 30,724 | 30,724 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 19,306 | 19,306 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 27,881 | 50,312 | - | - | Common Stock | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 27,881 | 55,763 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 40.42 per share. | 16 Jun 2025 | 13,608 | 36,704 | - | 40.4 | 550,035 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 46.29 per share. | 18 Mar 2025 | 1,284 | 24,871 | - | 46.3 | 59,436 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 47.40 per share. | 18 Mar 2025 | 1,254 | 23,617 | - | 47.4 | 59,440 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 50.11 per share. | 18 Mar 2025 | 1,186 | 22,431 | - | 50.1 | 59,430 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 8,019 | 24,060 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 8,019 | 26,155 | - | - | Common Stock | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 30,628 | 30,628 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 20,089 | 20,089 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2024 | 27,881 | 83,644 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2024 | 27,881 | 28,581 | - | - | Common Stock | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Sale of securities on an exchange or to another person at price $ 27.47 per share. | 17 Jun 2024 | 10,445 | 18,136 | - | 27.5 | 286,924 | Common Stock |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 47,500 | 47,500 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 32,079 | 32,079 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 163,397 | 163,397 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Jeffrey S. Farrow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 111,525 | 111,525 | - | - | Restricted Stock Units |